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Thyroid transcription factor-2 (TTF2) is a nuclear protein involved in morphogenesis and gene expression in thyroid gland, belonging to
the family of the forkhead/winged-helix transcription factors. In the present study we have investigated the sequence determinants for
transport and accumulation into the nucleus of the TTF2 protein. By transient expression of fusion proteins constructed by joining different
parts of TTF2 to the reporter gene of the jellyfish green fluorescent protein (GFP) and, in a separate set of deleted constructs, the glutathione
S-transferase (GST) coding sequence, we have demonstrated that a basic amino acid stretch present at both ends of the DNA-binding domain
is a bona fide nuclear localization signal (NLS). We have analyzed the subcellular localization of deleted GFP-GST-TTF2 fusion proteins and
have shown that residues inside the forkhead domain (FHD) contributed to the complete nuclear TTF2 protein accumulation. Furthermore, by
means of GST binding assays we have shown that distinct TTF2 fragments, containing the NLS, were able to bind the nuclear import
receptor importin a. Taken together, our results provide the first documentation about nuclear targeting of a forkhead protein containing two
identical NLS signal flanking the DNA-binding domain.
D 2003 Elsevier B.V. All rights reserved.Keywords: Nuclear localization signal; TTF2; Forkhead; FOXE1; FKHL15; Importin a1. Introduction
Thyroid transcription factor 2 (TTF2), also named
FOXE1 (Forkhead Box E1), is a member of a gene family
that encodes proteins characterized by an evolutionarily
conserved 110-amino-acid DNA-binding domain, known
as the forkhead domain (FHD) [1,2]. A unified nomencla-
ture that uses the FOX symbol (Forkhead box) has been
adopted for all chordate winged helix/forkhead transcription
factors [3]. Many members of the family of forkhead/
winged-helix transcription factors are key regulators of
embryogenesis and play important roles in cell differentia-
tion and development [4]. Recently, a number of mutations
in human FOX genes have been associated to specific
syndromes (i.e. Blepharophimosis/Ptosis/Epicanthus Inver-
sus Syndrome [5]; Axenfeld–Rieger syndrome [6]; speech
disorders [7], anterior segment ocular dysgenesis and cata-
racts [8]. TTF2 has been associated to thyroid agenesis, cleft
palate and choanal atresia [9].0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2003.09.002
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E-mail address: mariagrazia.romanelli@univr.it (M.G. Romanelli).Efficient nuclear localization of transcription factors is
essential for their function [10]. Nuclear proteins may
accumulate in the cell nucleus selectively and efficiently
by active transport mediated by specific nuclear localization
signal (NLS) recognized by cytosolic receptors [11,12]. The
canonical NLSs are characterized by short amino acid
stretches that are enriched in basic amino acid and may be
sufficient to confer nuclear localization when they are
conjugated to a carrier protein. The majority of NLSs
hitherto known fall into two well-defined classes, the first
one characterized by a short stretch of basic amino acids,
exemplified by the SV40 large T antigen NLS (T-ag
PKKKRKV), and the second one characterized by a bipartite
NLS, composed of two stretches of basic amino acids
separated by a spacer of 10–12 amino acids, exemplified
by nucleoplasmin (KR PAATKKAGQAKKKK ) [13]. The
proteins containing the ‘‘classical’’ NLSs are imported into
the nucleus by the importins a/hheterodimers. The a
importins contain the NLS binding site, whereas impor-
tins-h mediate the translocation through the nuclear pore
[14,15]. Highly homologous signal sequences may be
imported via a different import pathway [16].
In order to identify the functional domains required for
TTF2 nuclear localization, we have investigated the subcel-
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of TTF2. We have shown that a basic residues stretch
present at the boundaries of the FHD is a functional NLS
required for cytosolic receptor recognition.2. Materials and methods
2.1. Bioinformatic analyses
Amino acid sequences of FOX proteins were retrieved
using BLASTsearch program at the server supported through
NCBI (http://www.ncbi.nlm.nih.gov/blast/). FHD sequences
from human FOX proteins shown in Fig. 1 were aligned
using ClustalW, accessed through the EMBL European
Bioinformatic Institute (http://www2.ebi.ac.uk/clustalw/).
2.2. Construction of expression vectors
DNA manipulations and cloning experiments were
performed according to standard procedures [17]. The
GFP constructs were obtained by inserting either the
sequence coding for the entire human TTF2 protein or
parts of it into the SalI–BamHI cleaved pEGFP-C1
(enhanced green fluorescent protein C-terminal protein
fusion vector; Clontech Laboratories). PGFP-GST con-
struct contains the full-length glutathione S-transferase
(GST) coding sequence cloned in frame into the EcoRI–
SalI cleaved pEGFP-C1 vector. The GST sequence was
polymerase chain reaction (PCR)-amplified from pGEX-
5X-1 vector with forward primer 5V-CCGGAATTCTCCCC-
TATACTAGGTTATTG-3Vand reverse primer 5V-CAGG-
CATTCAGTCGACTCAGTCACGATGCGGCCGCT-3V.
The RRRKRmotif or portion of TTF2 DNA-binding domain
(residues 1 to 80, 1 to 110, 80 to 110, 80 to 151, and 110 to
151) was cloned separately into the SalI–BamHI cleaved
pGFP-GST expression vector. The TTF2 sequences were
obtained from the FKHL15 cDNA [18] by PCR using
the primers described below. Each pair contains a SalI
restriction site (forward primers, F) or a BamHI restriction
site (reverse primers, R) upstream to the sequence matching
the human TTF2 coding sequence (EMBL/GenBank acces-
sion number: U89995). F1: 5V-GGCAGGCATTCAGTCGAC
ATGACTGCCGAGAGCGGG-3 V; F2; 5V-GGAAGA-
CATTCAGTCGACCGCGGGAAGCCGCCCTAC-3V; F3: 5V-
GGAAGACATTCAGTCGAC AGCTTCCTGCG -
CCGCCGC-3V; F4: 5V-GGAAGACATTCAGTCGACAAGTT-
CATCACCGAGCGCTTCCCCTTCTAC-3 V; F5: 5 V-
GGAAGACATTCAGTCGACAAGTTCATCACC-
GAGCGCTTCCCCTTCTAC-3V; F6: 5V-GGAAGACA-
TTCAGTCGAC CGGCGCCGCAAGCGC-3 V; R1: 5 V-
CGCGGATCC TCACATGGCGGACACGAACCG-3V; R2:
5V-ATTGGATCCTCAGCGCTTGAAGCGCTT-3V; R3: 5V-
ATTGGATCC TCACTGCAGGGGGCGCTT-3 V; R4
GGCAGGCATTCAGTCGAC TCAGTCACGATGCGGCC-
GCT; R5: 5VGGCAGGCATTCAGTCGAC TCAGCGCTT-GCGGCGCCG-3V. Underlined nucleotides represent the
restriction sites. Deletions of the amino acid residues at
position 43–45 or 144–146 were obtained in two steps
PCR using primer R6: 5V-ATCCTCACTGCAGGGGGCGC-
TTCCCGCCCGCCCCGCGGCCCG TGGCCTCCCC-
TGGGA-3V, or primer R7 5V-CCTCAGCGCTTGAA-
GCGCTTCAGGAAGCTG CCGCTCTCGA ACATGT
CCTCCGCGTT-3V, respectively. The TTF2 deleted frag-
ments were amplified in the first PCR and the restriction
sites suitable for cloning were introduced in the second
PCR using primers F1 and R2, or F1 and R3. Deletions
in the FHD were obtained by recombinant PCR ap-
proach using the following primers: F 5V-ATCGCGCT-
CATCGCCATCGCGCACGCG-3 Vand R 5 V-CGCG-
TGCGCGATGGCGATGAGCGCGAT-3V for D 64–65; F
5V-CACGCGCCCGAGCTCACGCTGGGC-3Vand R 5V-
GCCCAGGTCGAGCTCGGGCGCGTG-3V for D 72–73;
F 5V-GAGCGCCGCCTCGGCGGCATCTACAAG-3V and
5V-CTTGTAGATGCCGCCGAGGCGGCGCTC-3Vfor D 75–
76; F 5V-TACCGCGACAACCCCTGGCAGAACAGCATC-
3 V a n d R 5 V- G A T G C T G T T C T G C C A G -
GGGTTGTCGCGGTA-3V for D 95 – 96; F 5V-TG-
GCAGAACAGCATCAACCTCACACTCAAC-3V and R5V-
GTTGAGTGTGAGGTTGATGCTGTTCTGCCA-3V for D
1 0 2 – 1 0 3 ; F 5 V- T T CC T CAAGATCCCGGC -
CGGCCGCCCG-3 V and R 5 V-CGGGCGGCCGGC-
CGGGATCTTGAGGAA-3V for D 116 – 117; F 5V-
CTCGACCCCAACGCGATGTTCGAGAGCGGC-3V and
RGCCGCTCTCGAACATCGCGTTGGGGTCGAG-3V for
D 134–135 (numbers indicate the amino acid residues
deleted). PGEX-TTF2 (1–151), pGEX-TTF2 (1–50),
pGEX-TTF2 (51–151) and pGEX-TTF2 (51–151) D
144–146 constructs were obtained by inserting the TTF2
sequences, obtained from FKHL15 cDNA by PCR amplifi-
cation with primers that introduced the EcoRI and HindIII
sites at the fragments ends, into EcoRI–HindIII cleaved
pGEX-5X-1 vector (Amersham Pharmacia Biotech) modi-
fied by introduction of a HindIII site.
2.3. Cell culture and transfection
Adherent HeLa cells were maintained in exponential
growth in Dulbecco’s modified Eagles medium supple-
mented with 10% fetal calf serum. Cells were grown on
glass coverslips and transfected using Lipofectamine (Life
Technologies) according to manufacturer’s instructions.
Forty-eight hours after transfection, cells were washed with
PBS and fixed in 2% paraformaldehyde in PBS at room
temperature for 20 min. Cellular localization of the GFP-
TTF2 fusion proteins was examined under a Leitz Orthoplan
microscope with an epifluorescence attachment.
2.4. Analysis of chimera proteins by Western blotting
Whole cells extracts were harvested in sample buffer (50
mM Tris–HCl pH 6.8, 2% SDS, 100 mM dithiothreitol,
Fig. 1. Panel A: Diagrammatic representation of the functional domains of human TTF2 protein. The TTF2 structural domains are diagrammed with boxes representing forkhead DNA-binding domain (FHD) and
the polyalanine stretch. Panel B: Alignment of the TTF2 forkhead DNA-binding domain with selected human FOX representatives. Alignment was performed by ClustalW Service at the European Bioinformatic
Institute. At the bottom, the consensus line indicates ‘*’ for identical or conserved residues in all sequences; ‘:’ for conserved substitutions; and ‘.’ for semi-conserved substitutions. The position of predicted ‘helix’
and ‘wing’ segments are indicated at the bottom of the panel.
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Fig. 2. Panel A: Schematic representation of expression vectors used to produces GFP-TTF2 fusion proteins. The hatched box corresponds to the FHD; the
black boxes correspond to the basic stretch RRRKR; deletions of basic residues are indicated with dotted boxes ; shaded boxes correspond to the GFP.
Numbers refer to TTF2 amino acids fused to GFP, or deleted (D). Panel B: The basic stretches at the boundaries of the TTF2 FHD are NLS. Fluorescence
micrographs of HeLa cells transfected with plasmids expressing GFP or fusions between GFP and parts of TTF2. Numbers refer to TTF2 amino acids fused to
GFP, or deleted (D).
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Fig. 3. Western blot analysis of GFP-TTF-2 fusion proteins transfected in
HeLa cells. HeLa whole cell extracts (10 Ag/lane) were separated by 12%
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose
membrane. The membrane was probed with polyclonal anti-GFP antiserum.
Panel A: Lane 1, GFP alone; lane 2, GFP-TTF2 (1–376); lane3, GFP-TTF2
(1–151); lane 4, GFP-TTF2 (152–376); lane 5, GFP-TTF2 (51–151) D
144–146; lane 6, GFP-TTF2 (1–50); lane 7, GFP-TTF2 (1–50) D 43–45;
lane 8, GFP-TTF2 (1–151) D 144–146; lane 9, GFP-TTF2 (51–151).
Molecular weight markers are shown on the left. Panel B: Lane 1, GFP
alone; lane 2, GFP-TTF2 (1–151) DMA; lane 3, GFP-TTF2 (1–151) DKK;
lane 4, GFP-TTF2 (1–151) DRH; lane 5, GFP-TTF2 (1–151) DRR; lane 6,
GFP-TTF2 (1–151) DTL; lane 7, GFP-TTF2 (1–151) DRE; lane 8, GFP-
TTF2 (1–151) DED. Molecular weight markers are shown on the left.
M.G. Romanelli et al. / Biochimica et Biophysica Acta 1643 (2003) 55–64 5910% glycerol, 0,1% bromophenol blue) from the transiently
transfected HeLa cells 48 h after transfection. The extracts
were subjected to 12% SDS-polyacrylamide gel electropho-
resis and analyzed by Western blotting using the rabbit
polyclonal GFP Antiserum (Invitrogen Life Technologies).
After incubation with the anti rabbit IgG alkaline phospha-
tase conjugated secondary antibody (Boehringer Man-
nheim), the proteins were visualized using a chromogenic
detection system (Boehringer Mannheim).
2.5. Expression of fusion proteins in Escherichia coli
The GST fusion system was used to generate chimeric
proteins. The pGEX-TTF2 (1–151), pGEX-TTF2 (1–50),
pGEX-TTF2 (51–151) and pGEX-TTF2 (51–151) D 144–
146 constructs were introduced into the E. coli strain BL21
(DE3). Cell culture and batch purification of the GST
fusion proteins were performed essentially according to
the manufacturer’s instruction (Amersham Pharmacia Bio-
tech). All the procedures were carried out at 4 jC; 1 mM
EGTA and 2 mM dithiothreitol (DTT) were included in the
buffers throughout the purification procedures. Recombi-
nant GST proteins, after elution, were dialyzed at 4 jC
against binding buffer (20 mM Hepes, 150 mM KOAc, 2
mM Mg (OAc)2, 2mM DTT). The concentration of proteins
was determined by the Bradford’s method using the Bio-
Rad dye reagent (Bio-Rad) and BSA as standard. Protein
samples were aliquoted, quick frozen in liquid N2, and
stored at  80 jC.
The E. coli strain BLR containing GST fusions of a
functional SV40 large T antigen nuclear localization signal
(Tag NLS) or an inverse version of Tag NLS (Tag NLSinv)
was cultured, and the proteins were purified as described
[19].
2.6. In vitro binding assay
The plasmid pRSET-hSRP1 containing human importin
a cDNA [20] was used to produce a [35S]-methionine-
labeled protein by means of the Promega TNT T7 Quick
Coupled Translation System. In vitro binding assays were
performed essentially as described [21]. Briefly, 15 Ag of
GST-TTF2 (1–151), GST-TTF2 (1–50), GST-TTF2 (51–
151) and GST-TTF2 (51–151) D 144–146 and 7 Ag of
GST-Tag NLS or GST-TagNLSinv were incubated with 40
Al of glutathione-agarose beads (Amersham Pharmacia
Biotech) in 0.5 ml of binding buffer (20 mM HEPES, pH
6.8, 150 mM KOAc, 2 mM Mg (OAc)2, 2 mM DTT, 0.1%
Tween 20) for 2 h at 4 jC. One-twentieth of the beads was
removed and the amount of immobilized GST fusion
proteins was analyzed by SDS-PAGE. The rest of the beads
was incubated with 90 Al of in vitro translated importin a
reaction mixture for 4 h at 4 jC, then washed in binding
buffer and boiled in 30 Al of sample buffer; the immobilized
proteins were resolved on a SDS-10% polyacrylamide gel.
The 35S-labeled importin a bound to the GST fusionproteins was detected by fluorography using Amplify
Reagent (Amersham Pharmacia Biotech).3. Results and discussion
3.1. The basic motif at the N- and C-terminal ends of the
TTF2 FHD is a functional NLS
The TTF2 gene sequence, located on chromosome 9q22,
is organized in one exon and encodes for a protein of 376
amino acids. TTF2 cDNAs have been isolated from a cDNA
library enriched for transcripts from chromosome 9q22
(identified as FKHL15, forkhead-like gene 15) [18], and
from a human genomic library [22].
Fig. 4. Panel A: The amino acid sequence of the TTF2 FHD. Residues underlined indicate NLS stretches. Residues in bold were deleted in the fusion proteins analyzed by transfections, as shown in panel B. The
positions of predicted ‘helix’ and ‘wing’ segments are indicated below the amino acid sequence. S1, S2 and S3 indicate extension of the h strands. T denotes turn region. Panel B: Residues in the FHD contribute to
GFP-TTF2 (1–151) full nuclear accumulation. Fluorescence micrographs of HeLa cells transfected with plasmids expressing GFP-TTF2 (51–151) or GFP-TTF2 (1–151) fusion proteins. Letters close to D
indicate deleted residues.
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in addition to the FHD, a second domain rich in alanine
residues that has been found in other developmental
DNA binding proteins responsible for transcriptional
repression activity [23–26] and two short stretches of
basic amino acids (RRRKR) at both ends of the FHD
(Fig. 1, panel A). Sequence alignments of representative
human FOX proteins segments, containing the FHD and
its N- and C-terminal boundaries, show that a stretch of
basic amino acids is present in most of the proteins at the
C-terminal of DNA-binding domain (Fig. 1, panel B),
whereas a basic stretch at the N-terminal of the DNA-
binding domain is less conserved (i.e. FOXE3 and
FOXH1, other than TTF2). Previous studies have
demonstrated that the basic stretches at the C-terminal
of the FHD are bona fide NLSs in four FOX proteins
[27–30]. These sequences differ from the basic stretch
present at both ends of TTF2 FHD.
In order to analyze the contribution to nuclear localiza-
tion of the N- and C-terminal ends of TTF2 FHD, we
produced recombinant vectors (Fig. 2A) expressing the
complete TTF2 protein, or parts thereof, individually fused
to the C-terminal of the GFP, which usually diffuses to the
nucleus (Fig. 2B, a). The pGFP-TTF2 vector expresses a
chimeric protein of approximately 70 kDa that may not pass
through the nuclear pore complex (NPC) passively. In
transfected HeLa cells the full-length GFP-TTF2 (1–376)
localized exclusively into the nucleus (Fig. 2B, b), indicat-
ing an active transport of the chimeric protein. We analyzedFig. 5. RRRKR is a bona fide NLS. Fluorescence micrographs of HeLa cells tra
(1–80) (panel b), pGFP-GST-TTF2 (1–110) (panel c), pGFP-GST-TTF2 (80–1the contribution to nuclear accumulation of the TTF2
segment spanning residues 1–151, which contain the
FHD and its basic boundaries, compared to that of the
fragment 152 up to 376. Expression of GFP-TTF2 (1–151)
showed a strictly nuclear localization (Fig. 2B, c), whereas a
fusion protein in which the C-terminal residues 152 to 376
were present produced a diffuse fluorescence distributed
both in the cytoplasm and nucleus (Fig. 2B, d). We then
analyzed the contribution of each putative NLS to the
nuclear transport of GFP-TTF2 fused proteins. GFP-TTF2
(1–50), accumulated predominantly within the nucleus of
transfected cells, even if not exclusively (Fig. 2B, e),
whereas deletion of residues 43–45 in the putative NLS
produced a signal distributed equally in the cytoplasm and
the nucleus (Fig. 2B, f). When we analyzed the cellular
distribution of a chimeric GFP-TTF2 (1–151) protein,
which was deleted of residues 144–146 in the second
putative NLS, the protein displayed a nuclear localization
(Fig. 2B, g), similar to that observed with the expression of
the chimeric protein GFP-TTF2 (51–151) (Fig. 2B, h).
Deletion of residues 144–146 in the GFP-TTF2 (51–151)
abolished the strictly nuclear localization (Fig. 2B, i). Taken
together, these results indicate that the basic stretches at the
N- and C-terminal ends of the FHD contribute to nuclear
translocation. The only construct containing the basic
stretch that did not accumulated completely into the nucleus
was the smaller fusion protein GFP-TTF2 (1–50). Western
blotting using anti-GFP antibody have shown an appropriate
full-length expression of all of the GFP-TTF-2 fusionnsfected separately with pGFP-GST-RRRKR (panel a), pGFP-GST-TTF2
51) (panel d), and pGFP-GST-TTF2 (110–151) (panel e).
Fig. 6. Binding of importin a to TTF2. GST-TTF2 (1–151), GST-TTF2
(1–50), GST-TTF2 (51–151), GST-TTF2 (51–151) 144–146, GST-NLS
or GST-NLSinv, fusion proteins immobilized on glutathione sepharose 4B,
were incubated with in vitro translated importin a labeled with [35S]-
methionine. The proteins were separated by SDS-10% PAGE gel, and
bound importin a was analyzed by fluorography (upper panel). An amount
representing 1/20 of the beads incubated with GST fusion proteins,
extensively washed, was resolved by SDS-PAGE and stained with
Coomassie brilliant blue (lower panel, CBB staining).
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might derived by protein degradation. Plausibly, the cyto-
plasmic distribution of the fluorescent signal of GFP-TTF2
(1–50) could be the result of passive diffusion through the
NPC, in addition to a less efficient nuclear retention due to
the absence of the DNA-binding domain. The involvement
of DNA recognition motifs in nuclear accumulation has
been demonstrated for two thyroid transcription factors: in
TTF1 a nuclear targeting sequence is located in the DNA
recognition helix of the homeodomain and acts in concert
with a basic NLS identified at the N-terminal end of the
homeodomain. [31]; in the Pax 8 factor, the paired box that
interacts with the DNA contributes to nuclear localization in
addition to a second region located in the residual homeo-
domain [32].
In order to investigate the contribution to nuclear accu-
mulation or retention of residues inside of the TTF2 FHD,
we analyzed the cellular distribution of different fusion
proteins expressing TTF2 fragments 1–151 mutated by
deletions in the DNA-binding domain (Fig. 4, panel A).
All constructs were analyzed by Western blotting using an
anti-GFP antibody to ascertain the appropriate full length
(Fig. 3B).
A strictly nuclear localization was observed when dele-
tions at positions 64–65 (DMA), 75–76 (DTL), 95–96
(DKK), 116–117 (DRE) or 134–135 (DED) were intro-
duced separately in the GFP-fusion proteins (Fig. 4B, b, d,
e, g, h), whereas an additional cytoplasmic distribution of
the fluorescent signal appeared by deletion of residues 72–
73 (DRR), between helix 1 and 2 of the FHD and, less
evident, by deletion of residues 102–103 (DRH), in helix 3
(Fig. 4B, c, f). The cytoplasmic distribution of the fluores-
cence signal expressed by DRR and DRH constructs might
be due to a less efficient nuclear retention of the deleted
fusion proteins, which are proximal to the passive limit of
diffusion, or to a presence of a more complex NLS sequence
at the N-terminal of FHD. In order to address this issue, we
have made a construct that contains the TTF2 RRRKR motif
cloned into a pGFP-GST vector, expressing a fusion protein
larger than the passive diffusion limit through the NPC. As
shown in Fig. 5 (panel a), the fusion protein was distributed
exclusively into the nucleus, but compared to the nuclear
localization of the GFP-TTF2 (1–376), the punctuated
subnuclear accumulation disappeared. We further analyzed
the expression of fusion proteins containing parts of the
FHD. Expression in transfected HeLa cells of residues 1 to
80, 1 to 110, 80 to151 or 110 to 151, fused separately to
GFP-GST, showed an exclusive nuclear distribution (Fig. 5,
b, c, d, e). The punctuated pattern of nuclear accumulation
disappeared in the distribution of fusion proteins deleted at
the N-terminal of the FHD up to residue 110. These results
demonstrated that the basic stretch RRRKR is a bona fide
NLS, and that residues at the N-terminal FHD may contrib-
ute to nuclear retention.
The functional contribution to nuclear localization given
by the N- and C-terminal boundary of the FHD has beendemonstrated for FOXA2 and FOXF2 [23,24]. In FOXC1
and FOXO4, only the basic region conserved at the C-
terminal end of the FHD has been demonstrated to
represents a bona fide NLS [25,26]. The presence of
nuclear determinants close to, or inside to, the DNA
binding are often demonstrate in DNA and RNA binding
proteins [33,34]. The presence of identical NLSs near or
within the domain involved in DNA or RNA binding is
less frequent. TTF2 is the only human FOX protein that
contains identical basic stretches at the N- and C-terminal
ends.
3.2. TTF2 binds importin a
Proteins carrying ‘‘classical’’ NLSs bind generally to the
cytoplasmic receptors belonging to the importin a family.
There are, however, many exceptions to this type of import,
derived from different types of cytoplasm receptors that can
recognize the NLS [10], or the NLS that bind directly to
importin h, independently of importin a [35], or proteins
that can translocate through the NPCs in the absence of any
M.G. Romanelli et al. / Biochimica et Biophysica Acta 1643 (2003) 55–64 63soluble factors [36,37]. We tested the ability of a human
importin a to bind the fragment of TTF2 containing both
NLSs, or a single one, compared to the fragment mutated by
deletions in both NLSs. We performed binding assays using
in vitro translated importin a and recombinant GST-TTF2
fusion proteins expressed in bacterial cells. We used GST
fusion proteins with SV40 Tag NLS (GST-NLS) or an
inverse version of Tag NLS (GST-NLSinv) as positive and
negative controls, respectively, of importin a binding. As
shown in Fig. 6, importin a binds to GST-TTF2 (1–151),
GST-TTF2 (1–50) and GST-TTF2 (51–151). Importin a
binding was not detected using the GST-TTF2 (51–151) D
144–146 peptide that contains the FHD deleted of basic
residues at either end. These results suggest that TTF2
nuclear import occurs via an importin a-dependent pathway
and that at least one of the two NLSs is required for
cytosolic receptor recognition.
In conclusion, we have identified the structural determi-
nants for TTF2 nuclear localization. We have shown that
TTF2 protein contains two identical bona fide NLSs at both
ends of the DNA-binding domain that are required for
importin a receptor binding. In addition, we have shown
that residues inside the FHD may contribute to full accu-
mulation of the TTF2 protein into the nucleus.Acknowledgements
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